Evidence of clinically significant interstitial lung disease or active, noninfectious pneumonitis.
Evidence of clinically significant interstitial lung disease or active, noninfectious pneumonitis.
Evidence of clinically significant interstitial lung disease or active, noninfectious pneumonitis.
Evidence of interstitial lung disease or noninfectious pneumonitis.
Has known history of or any evidence of active, noninfectious pneumonitis
Known history of, or any evidence of, interstitial lung disease or active noninfectious pneumonitis
Has known history of, or any evidence of active, noninfectious pneumonitis
Patient has history of interstitial lung disease or known history of, or any evidence of active, noninfectious pneumonitis
DOSE ESCALATION COHORT: Evidence of or any history of interstitial lung disease or active, noninfectious pneumonitis including symptomatic and/or pneumonitis requiring treatment
DOSE EXPANSION COHORT: Evidence of or any history of interstitial lung disease or active, noninfectious pneumonitis including symptomatic and/or pneumonitis requiring treatment
Evidence of interstitial lung disease or active, noninfectious pneumonitis
Evidence of active, noninfectious pneumonitis or history of interstitial lung disease.
Has evidence or history of interstitial lung disease or active noninfectious pneumonitis
Evidence of active noninfectious pneumonitis or history of interstitial lung disease.
Patients with interstitial lung disease or active, noninfectious pneumonitis
Evidence of active, noninfectious pneumonitis or history of interstitial lung disease.
Known history of, or any evidence of, interstitial lung disease or active noninfectious pneumonitis.
